CA2413883A1 - Procede de prevention de dommages tissulaires associes a une reaction du greffon contre l'hote ou une reaction de l'hote contre le greffon qui suit une transplantation - Google Patents

Procede de prevention de dommages tissulaires associes a une reaction du greffon contre l'hote ou une reaction de l'hote contre le greffon qui suit une transplantation Download PDF

Info

Publication number
CA2413883A1
CA2413883A1 CA002413883A CA2413883A CA2413883A1 CA 2413883 A1 CA2413883 A1 CA 2413883A1 CA 002413883 A CA002413883 A CA 002413883A CA 2413883 A CA2413883 A CA 2413883A CA 2413883 A1 CA2413883 A1 CA 2413883A1
Authority
CA
Canada
Prior art keywords
versus
host
graft
tissue damage
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002413883A
Other languages
English (en)
Other versions
CA2413883C (fr
Inventor
George B. Mcdonald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enteron Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2413883A1 publication Critical patent/CA2413883A1/fr
Application granted granted Critical
Publication of CA2413883C publication Critical patent/CA2413883C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002413883A 2000-05-22 2000-05-22 Procede de prevention de dommages tissulaires associes a une reaction du greffon contre l'hote ou une reaction de l'hote contre le greffon qui suit une transplantation Expired - Lifetime CA2413883C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/014064 WO2001089529A1 (fr) 2000-05-22 2000-05-22 Procede de prevention de dommages tissulaires associes a une reaction du greffon contre l'hote ou une reaction de l'hote contre le greffon qui suit une transplantation

Publications (2)

Publication Number Publication Date
CA2413883A1 true CA2413883A1 (fr) 2001-11-29
CA2413883C CA2413883C (fr) 2009-07-28

Family

ID=21741408

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002413883A Expired - Lifetime CA2413883C (fr) 2000-05-22 2000-05-22 Procede de prevention de dommages tissulaires associes a une reaction du greffon contre l'hote ou une reaction de l'hote contre le greffon qui suit une transplantation

Country Status (3)

Country Link
AU (1) AU2000250389A1 (fr)
CA (1) CA2413883C (fr)
WO (1) WO2001089529A1 (fr)

Also Published As

Publication number Publication date
CA2413883C (fr) 2009-07-28
WO2001089529A1 (fr) 2001-11-29
AU2000250389A1 (en) 2001-12-03

Similar Documents

Publication Publication Date Title
US20030224071A1 (en) Pharmaceutical compositions and methods for managing connective tissue ailments
US6676977B2 (en) Pharmaceutical compositions and methods for reducing the appearance of cellulite
Mourelle et al. Toxic dilatation of colon in a rat model of colitis is linked to an inducible form of nitric oxide synthase
WO2007032962A3 (fr) Compositions et procédés destinés à une administration intranasale de cannabidoïdes tricycliques
AU609090B2 (en) Composition for treatment of acne
CA2389167A1 (fr) Formulations pharmaceutiques de resveratrol et leurs procedes d'utilisation
CA2477301A1 (fr) Procedes d'utilisation de composes immunomodulateurs pour le traitement et la gestion des syndromes myelodysplastiques et compositions contenant ces composes
AR021922A1 (es) Formulaciones farmaceuticas en aerosol que contienen fluoroalcanos, budesonido y formoterol.
CA2373852A1 (fr) Acides aldoniques oligosides et leur usage topique
WO2001090091A8 (fr) Inhibiteurs de 11-beta-hydroxy-steroide-deshydrogenase de type 1
MXPA05004778A (es) Metodos de uso y composiciones que contienen compuestos inmunomoduladores para el tratamiento y manejo de enfermedades mieloproliferativas.
CA2328950A1 (fr) Derives de piperidinopyrimidine pour application topique
Swanson Prevention of dry socket: an overview
WO2004028480A3 (fr) Inhibiteurs de proteine regulant la permeabilite transmembranaire de la fibrose kystique (cftr) et uitlisations
IL158903A0 (en) Use of sulodexide for the treatment of inflammatory bowel disease
WO2007022509A3 (fr) Utilisation des inhibiteurs de seh en tant qu'analgesiques
US20050281820A1 (en) Compositions and methods for treating burns
EP1057484A4 (fr) Inhibiteurs de la mort cellulaire
CA2271162A1 (fr) Compositions d'acide stearidonique et utilisations correspondantes
AR021921A1 (es) Formulaciones farmaceuticas en aerosol que contienen fluoroalcanos y budesonido.
Misseghers et al. Clinical observations of the treatment of canine perianal fistulas with topical tacrolimus in 10 dogs.
NO20055601L (no) Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer
WO2001074807A1 (fr) Derives indolylpyrrole et inhibiteurs de mort cellulaire
WO2002102743A3 (fr) Aminoalkylesters d'acide diphenylalcoxy-acetique n et alpha-substitues deuterises et medicaments contenant lesdits composes
JP2000143486A (ja) 皮膚外用剤

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20200522